| Original language | English |
|---|---|
| Journal | BMC Infectious Diseases |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2016 |
Keywords
- Clostridium difficile
- Incidence
- Internal Medicine
- Outcome
- Predictors
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: Findings from the nationwide FADOI-PRACTICE study. / Cioni, G.; Viale, P.; Frasson, Stefania et al.
In: BMC Infectious Diseases, Vol. 16, No. 1, 2016.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: Findings from the nationwide FADOI-PRACTICE study
AU - Cioni, G.
AU - Viale, P.
AU - Frasson, Stefania
AU - Cipollini, F.
AU - Menichetti, Francesca
AU - Petrosillo, N.
AU - Brunati, Sergio
AU - Spigaglia, Patrizia
AU - Vismara, C.
AU - Bielli, Alessandra
AU - Barbanti, Francesca
AU - Landini, G.
AU - Panigada, G.
AU - Gussoni, Gualberto
AU - Bonizzoni, Erminio
AU - Gesu, Giovanni Pietro
AU - Costantino, A.
AU - Masciari, R.
AU - Amato, G.
AU - Fontanella, A.
AU - Gallucci, F.
AU - Improta, L.
AU - Poggiano, M. R.
AU - Rabitti, P. G.
AU - Uomo, G.
AU - Civardi, Giuseppe
AU - Confalonieri, M.
AU - Grandi, M.
AU - Sacchetti, C.
AU - Baldini, T.
AU - Miglioli, S.
AU - Sarti, M.
AU - Landini, M. P.
AU - Panuccio, Domenico
AU - Romboli, Elisabetta
AU - Vocale, C.
AU - Berti, F.
AU - Bonito, L.
AU - Gozzo, M. L.
AU - Manfellotto, D.
AU - Natili, S.
AU - Patti, A.
AU - Piccolo, P.
AU - Pistella, E.
AU - Santini, C.
AU - Pastorelli, R.
AU - Pellegrinotti, M.
AU - Quaratino, C. P.
AU - Bona, Alberto R.
AU - Gnerre, P.
AU - Lillo, F.
AU - Parodi, L.
AU - Bovero, A.
AU - Santoriello, L.
AU - Agnelli, F.
AU - Colombo, F.
AU - Gesu, G.
AU - Lombardi, G.
AU - Lanzetti, V.
AU - Biagiotti, Sara
AU - Clerici, Pierangelo
AU - Mazzone, A.
AU - Brusco, G.
AU - Magnani, L.
AU - Tirella, S.
AU - Terulla, Cristina
AU - Manso, E.
AU - Nitti, C.
AU - Salvi, A.
AU - Ciarambino, T.
AU - Pepe, C.
AU - Politi, Carola
AU - Frediani, R.
AU - Moschella, A.
AU - Lodolo D'Oria, Agnese
AU - Barasolo, Gabriele
AU - Bertoncelli, Maria Cristina
AU - Milano, F.
AU - Campanini, M.
AU - Molinari, G. L.
AU - Pittau, S.
AU - De Bernochi, A.
AU - Giusti, M.
AU - Montegrosso, G.
AU - Errico, M. E.
AU - Mastroianni, F.
AU - Tauro, L.
AU - Caddori, A.
AU - Prasciolu, C. G.
AU - Naso, C.
AU - Romano, M.
AU - D'Angelo, A.
AU - Genco, L.
AU - Mangano, G.
AU - Arena, F.
AU - Biagioni, Chiara
AU - Cimolato, B.
AU - Nozzoli, C.
AU - Poli, A.
AU - Rossolini, G.
AU - Burzigotti, F.
AU - Francioni, S.
AU - Lenti, Salvatore
AU - Galanti, I. A.
AU - Belcari, Claudio
AU - Longo, B.
AU - Salamone, D.
AU - Chiti, I.
AU - Lencioni, Patrizia
AU - Teghini, L.
AU - Gambacorta, M.
AU - Perrotta, U.
AU - Battaglia, G.
AU - Ely Pizzato, P.
AU - Vian, A.
AU - De Menis, Ernesto
AU - Bordignon, G.
AU - Tramontin, P.
AU - Doroldi, Carlo
AU - Ravagnan, P.
AU - Sartore, Paola
AU - Leoni, M.
AU - Pauletto, P.
AU - Rigoli, Roberto
AU - Callegari, C.
AU - Sacchetta, A. C.
AU - Vendrame, A.
N1 - Export Date: 20 March 2017 CODEN: BIDMB Correspondence Address: Gussoni, G.; Clinical Research Department, FADOI Foundation, Piazzale L. Cadorna, 15, Italy; email: gualberto.gussoni@gmail.com References: Surawicz, C.M., Brandt, L.J., Binion, D.G., Ananthakrishnan, A.N., Curry, S.R., Gilligan, P.H., Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections (2013) Am J Gastroenterol, 108, pp. 478-498; Debast, S.B., Bauer, M.P., Kuijper, E.J., European Society of Clinical Microbiological and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection (2014) Clin Microbiol Infect, 20, pp. 1-26; Planche, T.D., Davies, K.A., Coen, P.G., Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection (2013) Lancet Infect Dis, 13, pp. 936-945; Dubberke, E.R., Reske, K.A., Yan, Y., Olsen, M.A., McDonald, L.C., Fraser, V.J., Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors (2007) Clin Infect Dis, 45, pp. 1543-1549; Dial, S., Delaney, J.A., Barkun, A.N., Suissa, S., Use of gastric acidsuppressive agents and the risk of community-acquired Clostridium difficile-associated disease (2005) JAMA, 294, pp. 2989-2995; Huang, S.S., Datta, R., Platt, R., Risk of acquiring antibiotic-resistant bacteria from prior room occupants (2006) Arch Intern Med, 166, p. 1945; Ben-Horin, S., Margalit, M., Bossuyt, P., Maul, J., Shapira, Y., Bojic, D., Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection (2009) Clin Gastroenterol Hepatol, 7, pp. 981-987; Lo Vecchio, A., Zacur, G.M., Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options (2012) Curr Opin Gastroenterol, 28, pp. 1-9; Johnson, S., Adelmann, A., Clabots, C.R., Peterson, L.R., Gerding, D.N., Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism (1989) J Infect Dis, 159, pp. 340-343; Louie, T.J., Miller, M.A., Mullane, K.M., Weiss, K., Lentnek, A., Golan, Y., Fidaxomicin versus vancomycin for Clostridium difficile infection (2011) N Engl J Med, 364, pp. 422-431; Zilberberg, M.D., Shorr, A.F., Kollef, M.H., Increase in adult Clostridium difficile-related hospitalizations and case fatality rate, United States, 2000-2005 (2008) Emerg Infect Dis, 14, pp. 929-931; McDonald, L.C., Owings, M., Jernigan, D.B., Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 (2006) Emerg Infect Dis, 12, pp. 409-415; Martin, M., Zingg, W., Knoll, E., Wilson, C., National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review (2014) J Hosp Infect, 87, pp. 212-219; van Dorp, S.M., Kinross, P., Gastmeier, P., Behnke, M., Kola, A., Delmée, M., Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013 (2016) Euro Surveill, 21; Sansone, S., Aschbacher, R., Staffler, M., Bombonato, M., Girardi, L.C., Nosocomial diarrhea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital (2009) J Prev Med Hyg, 50, pp. 117-120; Bauer, M.P., Notermans, D.W., Benthem, B.H.B., Wilcox, M.H., Rupnik, M., Monnet, D.L., Clostridium difficile infection in Europe: a hospital-based survey (2011) Lancet, 377, pp. 63-73; Bella, S., Musso, M., Cataldo, M.A., Meledandri, M., Bordi, E., Capozzi, D., Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011 (2013) BMC Infect Dis, 13, pp. 146-152; Mellace, L., Consonni, D., Jacchetti, G., Medico, M., Colombo, R., Velati, M., Epidemiology of Clostridium difficile-associated disease in internal medicine wards in northern Italy (2013) Intern Emerg Med, 8, pp. 717-723; Davies, K.A., Longshaw, C.M., Davis, G.L., Bouza, E., Barna, Z., Fitzpatrick, F., Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID) (2014) Lancet Infect Dis, 14, pp. 1208-1219; Gravel, D., Miller, M., Simor, A., Taylor, G., Gardam, M., McGeer, A., Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study (2009) Clin Infect Dis, 48, pp. 568-576; Indra, A., Huhulescu, S., Schneeweis, M., Hasenberger, P., Kernbichler, S., Fiedler, A., Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping (2008) J Med Microbiol, 57, pp. 1377-1382; Spigaglia, P., Barbanti, F., Morandi, M., Moro, M.L., Mastrantonio, P., Aspetti microbiologici delle infezioni da Clostridium difficile in Italia: risultati di uno studio condotto negli anni 2012-2013 (2014) Microbiologia Medica, 29, p. 4722; Otten, A.M., Reid-Smith, R.J., Fazil, A., Weese, J.S., Disease transmission model for community-associated Clostridium difficile infection (2010) Epidemiol Infect, 138, pp. 907-914; Khanna, S., Pardi, D.S., Aronson, S.L., The epidemiology of community-acquired Clostridium difficile infection: a population-based study (2011) Am J Gastroenterol, 107, pp. 89-95; Kyne, L., Hamel, M.B., Polavaram, R., Kelly, C.P., Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile (2002) Clin Infect Dis, 34, pp. 346-353; Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06 (2008) Health Stat Q, 37, pp. 52-56; Nogareda, F., Soler, P., Llacer, A., Increases in Clostridium difficile-related mortality rates in Spain (1999-2006) (2009) Enferm Infecc Microbiol Clin, 27, pp. 484-485; Gabriel, L., Beriot-Mathiot, A., Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review (2014) J Hosp Infect, 88, pp. 12-21; Lowy, I., Molrine, D.C., Leav, B.A., Blair, B.M., Baxter, R., Treatment with monoclonal antibodies against Clostridium difficile toxins (2010) N Engl J Med, 362, pp. 197-205; Drekonja, D.M., Butler, M., MacDonald, R., Bliss, D., Filice, G.A., Comparative effectiveness of Clostridium difficile treatments: a systematic review (2011) Ann Intern Med, 155, pp. 839-847; Hensgens, M.P., Dekkers, O.M., Demeulemeester, A., Buiting, A.G., Bloembergen, P., Benthem, B.H., Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study (2014) Clin Micriobiol Infect, 20, pp. 1067-1074; Boone, J.H., Goodykoontz, M., Rhodes, S.J., Price, K., Smith, J., Gearhart, K.N., Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency (2012) Eur J Clin Microbiol Infect Dis, 31, pp. 1551-1559; Janarthanan, S., Ditah, I., Adler, D.G., Ehrinpreis, M.N., Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis (2012) Am J Gastroenterol, 107, pp. 1001-1010; Tlevieh, I.M., Bin Abdulhak, A.A., Riaz, M., Alasmari, F.A., Garbati, M.A., Al Ghamdi, M., Association between proton pump inhibitor therapy and Clostridium difficile infection: a contemporary systematic review and meta-analysis (2012) PLoS One, 7; Chandra, S., Agarwal, D., Surana, A., Risk of Clostridium difficile infection with acid-suppressive therapy: pitfalls in accurate estimation (2013) Am J Gastroenterol, 108, pp. 277-278; Freedberg, D.E., Abrams, J.A., Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea (2013) Am J Gastroenterol, 108, pp. 278-279; Polage, C.R., Gyorke, C.E., Kennedy, M.A., Leslie, J.L., Chin, D.L., Wang, S., Overdiagnosis of Clostridium difficile infection in the molecular test era (2015) JAMA Intern Med, 175, pp. 1792-1801; Freeman, J., Vernon, J., Morris, K., Nicholson, S., Todhunter, S., Longshaw, C., Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes (2015) Clin Microbiol Infect, 21, pp. 248.e9-248.e16; Bella, S., Paglia, M.G., Johnson, E., Petrosillo, N., Clostridium difficile 027 infection in Central Italy (2012) BMC Infect Dis, 12, p. 370; Cartman, S.T., Heap, J.T., Kuehne, S.A., Cockayne, A., Minton, N.P., The emergence of "hypervirulence" in Clostridium difficile (2010) Int J Med Microbiol, 300, pp. 387-395
PY - 2016
Y1 - 2016
KW - Clostridium difficile
KW - Incidence
KW - Internal Medicine
KW - Outcome
KW - Predictors
U2 - 10.1186/s12879-016-1961-9
DO - 10.1186/s12879-016-1961-9
M3 - Article
VL - 16
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
SN - 1471-2334
IS - 1
ER -